IRIS
LAZZERINI, PIETRO ENEA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 7.226
EU - Europa 6.565
AS - Asia 1.194
AF - Africa 54
SA - Sud America 15
OC - Oceania 14
Continente sconosciuto - Info sul continente non disponibili 8
AN - Antartide 1
Totale 15.077
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.194
GB - Regno Unito 1.736
IE - Irlanda 1.165
IT - Italia 816
CN - Cina 769
SE - Svezia 698
DE - Germania 585
UA - Ucraina 527
RU - Federazione Russa 391
FR - Francia 316
SG - Singapore 170
FI - Finlandia 169
VN - Vietnam 125
CI - Costa d'Avorio 47
ES - Italia 44
IN - India 40
BE - Belgio 33
TR - Turchia 29
CA - Canada 26
CZ - Repubblica Ceca 21
NL - Olanda 18
TH - Thailandia 18
GR - Grecia 17
AU - Australia 11
EU - Europa 7
IL - Israele 6
IR - Iran 6
BR - Brasile 5
PL - Polonia 5
HK - Hong Kong 4
AE - Emirati Arabi Uniti 3
CL - Cile 3
EG - Egitto 3
HR - Croazia 3
MY - Malesia 3
NZ - Nuova Zelanda 3
PE - Perù 3
PK - Pakistan 3
RO - Romania 3
SK - Slovacchia (Repubblica Slovacca) 3
AR - Argentina 2
BG - Bulgaria 2
BY - Bielorussia 2
DK - Danimarca 2
ID - Indonesia 2
KG - Kirghizistan 2
KR - Corea 2
MX - Messico 2
PA - Panama 2
PH - Filippine 2
SI - Slovenia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AZ - Azerbaigian 1
BD - Bangladesh 1
CY - Cipro 1
DO - Repubblica Dominicana 1
EC - Ecuador 1
EE - Estonia 1
FK - Isole Falkland (Malvinas) 1
GS - Georgia del Sud e Isole Sandwich Australi 1
HU - Ungheria 1
IQ - Iraq 1
JM - Giamaica 1
JO - Giordania 1
JP - Giappone 1
KE - Kenya 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LT - Lituania 1
LU - Lussemburgo 1
MA - Marocco 1
NG - Nigeria 1
NO - Norvegia 1
RS - Serbia 1
SA - Arabia Saudita 1
SM - San Marino 1
TM - Turkmenistan 1
ZA - Sudafrica 1
Totale 15.077
Salva come PNG Salva come JPEG
Città #
Southend 1.606
Fairfield 1.169
Dublin 1.132
Ashburn 632
Chandler 599
Woodbridge 543
Houston 448
Jacksonville 424
Wilmington 420
Seattle 416
Cambridge 394
Menlo Park 308
Siena 308
Ann Arbor 291
Princeton 209
Beijing 199
Nanjing 155
Dong Ket 125
Singapore 113
Boardman 97
Dearborn 93
Helsinki 87
Vimercate 78
San Diego 74
New York 69
San Mateo 64
Nanchang 59
Moscow 58
Florence 53
Abidjan 47
Shanghai 41
Shenyang 41
Málaga 40
Brussels 33
Hebei 27
Milan 27
Lancaster 26
London 26
Izmir 24
Tianjin 23
Kunming 21
Norwalk 21
Toronto 21
Jinan 20
Jiaxing 19
Changsha 18
Fremont 17
Hefei 17
San Francisco 17
Falls Church 16
Pune 16
Guangzhou 15
Venezia 15
Düsseldorf 14
Lappeenranta 14
Munich 14
Ningbo 14
Washington 14
Brno 13
Dallas 13
Mestre 13
Zhengzhou 12
Chicago 11
Los Angeles 11
Redwood City 11
Caserta 10
Frankfurt am Main 10
Hangzhou 9
Pisa 9
Rome 9
Taizhou 9
Changchun 8
Paris 8
Livorno 7
Nicola 7
Olomouc 7
Phoenix 7
Sacramento 7
Aulla 6
Canberra 6
Fuzhou 6
Hounslow 6
Tappahannock 6
Turin 6
Amsterdam 5
Lanzhou 5
Petah Tikva 5
Prato 5
Anguillara Sabazia 4
Arezzo 4
Clifton 4
Grosseto 4
Modena 4
Queens 4
Santa Clara 4
Sinalunga 4
Athens 3
Auburn Hills 3
Bratislava 3
Campi Bisenzio 3
Totale 11.172
Salva come PNG Salva come JPEG
Nome #
Systemic inflammation as a novel QT-prolonging risk factor in patients with torsades de pointes 284
Marked QTc Prolongation and Torsades de pointes in Patients with Chronic Inflammatory Arthritis 247
Searching Novel Therapeutic Targets for Scleroderma: P2X7-Receptor Is Up-regulated and Promotes a Fibrogenic Phenotype in Systemic Sclerosis Fibroblasts 239
Arrhythmogenicity of Anti-Ro/SSA antibodies in patients with torsades de pointes 236
Adenosine A2A receptor activation stimulates collagen production in sclerodermic dermal fibroblasts either directly and through a cross-talk with the cannabinoid system 229
Proton pump inhibitors and serum magnesium levels in patients with Torsades de Pointes 229
P wave dispersion in cryptogenic stroke: A risk factor for cardioembolism? 227
Association between high sensitivity C-reactive protein, heart rate variability and corrected QT interval in patients with chronic inflammatory arthritis. 217
The purinergic P2×7 receptor is expressed on monocytes in Behçet's disease and is modulated by TNF-α 210
Antiarrhythmic potential of anti-cytokine therapy in rheumatoid arthritis: Tocilizumab reduces QTc interval by controlling systemic inflammation. 210
Non-HCV-related cryoglobulinemic vasculitis and parvovirus-B19 infection 204
Torsades de Pointes in patients with polymyalgia rheumatica 199
Antirheumatic agents in covid-19: is IL-6 the right target? 195
Spotlight on sirukumab for the treatment of rheumatoid arthritis: The evidence to date 192
Adenosine receptors expression in cardiac fibroblasts of patients with left ventricular dysfunction due to valvular disease 183
Synthetic cannabinoid ajulemic acid exerts potent antifibrotic effects in experimental models of systemic sclerosis 180
Systemic Inflammation Rapidly Induces Reversible Atrial Electrical Remodeling: The Role of Interleukin-6–Mediated Changes in Connexin Expression 178
Levels of circulating CXCR4-positive cells are decreased and negatively correlated with risk factors in cardiac transplant recipients 173
Anti-Ro/SSA-associated corrected QT interval prolongation in adults: the role of antibody level and specificity 172
Induction of autoimmune response to the extracellular loop of the HERG channel pore induces QTc prolongation in guinea-pigs 170
Isolated atrioventricular block of unknown origin in the adult and autoimmunity: Diagnostic and therapeutic considerations exemplified by 3 anti-Ro/SSA-associated cases 162
Assessing QT interval in patients with autoimmune chronic inflammatory diseases: perils and pitfalls 161
Connective tissue diseases and cardiac rhythm disorders: an overview 159
Statins and the joint: multiple targets for a global protection? 158
How to Identify Patients at Risk of Silent Atrial Fibrillation after Cryptogenic Stroke: Potential Role of P Wave Dispersion 156
Comparison of frequency of complex ventricular arrhythmias in patients with positive versus negative anti-Ro/SSA and connective tissue disease 154
Prolongation of the corrected QT interval in adult patients with anti-Ro/SSA positive connective tissue diseases 153
Increased arterial stiffness is an independent risk factor for hemorrhagic transformation in ischemic stroke undergoing thrombolysis 153
The role of P2X7 receptors in tissue fibrosis: a brief review 151
Autoimmune and inflammatory K+ channelopathies in cardiac arrhythmias: Clinical evidence and molecular mechanisms 151
Isolated atrioventricular block of unknown origin in adults and anti-Ro/SSA antibodies: Clinical evidence, putative mechanisms, and therapeutic implications 149
Cyclosporin and tacrolimus increase plasma levels of adenosine in kidney transplanted patients 149
Simvastatin inhibits T cell activation by selectively impairing the function of RAS superfamily GTPases 148
Early and delayed increase in plasma homocysteine levels in heart transplanted patients. 147
T lymphocytes as targets of statins: molecular mechanisms and therapeutic perspectives 146
Previous use of statins and atrial electrical remodeling in patients with cryptogenic stroke 146
Rosuvastatin inhibits spontaneous and IL-1β-induced interleukin-6 production from human cultured osteoblastic cells. 146
Pravastatin treatment-associated reduction in plasma homocysteine in heart-transplanted patients. 143
Changes of peripheral A2A adenosine receptors in chronic heart failure and cardiac transplantation 141
null 141
The "Invulnerability" of the Adult Conduction System to Anti-Ro/SSA Antibodies? A Matter of Calcium Channel Expression on the Cardiomyocyte 140
Autoantibody-mediated cardiac arrhythmias: mechanisms and clinical implications 139
Correlation between cardiac oxidative stress and myocardial pathology due to acute and chronic norepinephrine administration in rats 139
Systemic inflammation and arrhythmic risk: lessons from rheumatoid arthritis 139
Arrhythmic risk in rheumatoid arthritis: the driving role of systemic inflammation. 138
Inflammatory cytokines, life-threatening arrhythmias and premature mortality in chronic inflammatory arthritis: Time to focus on 138
Biologic drugs and arrhythmic risk in chronic inflammatory arthritis: the good and the bad 136
Autoimmune channelopathies as a novel mechanism in cardiac arrhythmias 136
Autoimmune Calcium Channelopathies and Cardiac Electrical Abnormalities 132
Acute effects of glibenclamide on reactive hyperaemia in the lower limbs in humans. 131
Reduction in plasma homocysteine level in patients with rheumatoid arthritis given pulsed glucocorticoid treatment. 131
The effects of age and hyperhomocysteinemia on the redox forms of plasma thiols 130
Homocysteine and Raynaud’s phenomenon: a review 128
Cardiac dysautonomia in patients with superior vena cava syndrome due to compression by lung cancer. 127
Anti-Ro/SSA antibodies and cardiac arrhythmias in the adult: facts and hypotheses 126
null 126
Androgen Deprivation Therapy for Prostatic Cancer in Patients With Torsades de Pointes 126
Psychosine-induced apoptosis and cytokine activation in immune peripheral cells of Krabbe patients. 125
null 124
null 122
null 122
Cardiac arrest risk during acute infections: systemic inflammation directly prolongs QTc interval via cytokine-mediated effects on potassium channel expression 122
Atrial cardiopathy and sympatho-vagal imbalance in cryptogenic stroke: Pathogenic mechanisms and effects on electrocardiographic markers 122
Human rheumatoid synoviocytes express functional P2X7 receptors 121
Cardioimmunology of arrhythmias: the role of autoimmune and inflammatory cardiac channelopathies 121
Combination Therapy With Ceftriaxone and Lansoprazole, Acquired Long QT Syndrome, and Torsades de Pointes Risk 119
Proton pump inhibitors directly block hERG-potassium channel and independently increase the risk of QTc prolongation in a large cohort of US Veterans 119
Statins as a new therapeutic perspective in myocarditis and postmyocarditis dilated cardiomyopathy 118
Cannabinoids inhibit fibrogenesis in diffuse systemic sclerosis fibroblasts 117
Pathogenesis of the novel autoimmune-associated long-QT syndrome 116
Corrected QT interval in anti-SSA-positive adults with connective tissue disease: Comment on the article by Lazzerini et al. [6] (multiple letters) 116
Comment on: Letter to the Editor from Clockaerts and Bierma-Zeinstra 115
Potassium Channel Block and Novel Autoimmune-Associated Long QT Syndrome 115
Emerging arrhythmic risk of autoimmune and inflammatory cardiac channelopathies 115
Arrhythmic risk during acute infusion of infliximab: a prospective, single-blind, placebo-controlled, cross-over study in patients with chronic arthritis 114
Interleukin-6 inhibition of hERG underlies risk for acquired long QT in cardiac and systemic inflammation 112
Oral low-dose dipyridamole protects from intravenous high-dose dipyridamole-induced ischemia. A oral echocardiographic study 110
Arrhythmogenic effects of anti-Ro/SSA antibodies on theadult heart: more than expected? 109
Photopheresis immunomodulation after heart transplantation. 108
Long QT Syndrome: An Emerging Role for Inflammation and Immunity 108
Simvastatin reduces MMP-3 level in interleukin 1b-stimulated human chondrocyte culture 106
null 105
Homocysteine and P wave dispersion in patients with heart transplantation 102
Hyperhomocysteinemia: a cardiovascular risk factor in autoimmunediseases? 102
Alteration in the redox state of plasma in heart transplanted patients with moderate hyperhomocisteinemia 101
Anti-Ro/SSA Antibodies Blocking Calcium Channels as a Potentially Reversible Cause of Atrioventricular Block in Adults 98
Simvastatin inhibits cytokine production and nuclear factor-kB activation in interleukin 1beta-stimulated synoviocytes from rheumatoid arthritis patients 98
Le indicazioni al trattamento con immunoglobuline endovena nelle malattie reumatiche. [Indications for intra-venous immunoglobulin treatment in rheumatic diseases] 98
P wave dispersion and silent atrial fibrillation in cryptogenic stroke: The pathogenic role of inflammation 97
Inhibitory effect of synthetic cannabinoids on cytokine production in rheumatoid fibroblast-like synoviocytes 96
Hyperhomocysteinemia, inflammation and autoimmunity 95
Comment on “Autoimmune hepatitis developing after coronavirus disease 2019 (COVID-19) vaccine: causality or casualty?” 93
Effects of acute administration of iloprost on the cardiac autonomic nervous system and ventricular repolarisation in patients with systemic sclerosis 92
Blunted increase in plasma adenosine levels following dipyridamole stress test in dilated cardiomyopathy patients 92
Commentary: Systemic effects of IL-17 in inflammatory arthritis 83
Neutrophil extracellular traps release in gout and pseudogout depends on the number of crystals regardless of leukocyte count 82
Electrocardiographic Predictors of Silent Atrial Fibrillation in Cryptogenic Stroke 80
Risk of qtc interval prolongation associated with circulating anti-ro/ssa antibodies among us veterans: an observational cohort study 75
Upregulation of A2A adenosine receptor expression by TNFa in PBMC of patients with CHF: a regulatory mechanism of inflammation 74
Transient hypogonadism is associated with heart rate-corrected QT prolongation and torsades de pointes risk during active systemic inflammation in men 69
Totale 13.978
Salva come PNG Salva come JPEG
Categoria #
all - tutte 50.069
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 50.069
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202.666 0 0 178 444 191 316 341 389 254 265 114 174
2020/20212.517 127 216 96 258 123 284 168 301 300 220 208 216
2021/20221.894 135 220 91 146 130 55 91 146 142 167 196 375
2022/20232.267 144 244 310 318 179 435 78 160 228 65 60 46
2023/20241.995 69 39 149 100 94 534 607 61 33 46 78 185
2024/2025625 89 201 335 0 0 0 0 0 0 0 0 0
Totale 15.406